Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Universite De Montpellier patents


Recent patent applications related to Universite De Montpellier. Universite De Montpellier is listed as an Agent/Assignee. Note: Universite De Montpellier may have other listings under different names/spellings. We're not affiliated with Universite De Montpellier, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "U" | Universite De Montpellier-related inventors


Methods for diagnosing hematological cancers

. . . . . . The present invention relates to methods for diagnosing hematological cancers. In particular, the present invention relates to a method for diagnosing a hematological cancer in a patient comprising i) detecting the presence of cd45raro nk cells in a sample obtained from the patient and ii) and concluding that the patient suffers from a hematological cancer when the presence of cd45raro nk cells is detected in the sample and the presence of at least one phenotypic marker indicates the nature of the haematological cancer.. ... Universite De Montpellier

Methods for screening compounds for treating or preventing a viral infection or a virus-related condition

The present invention relates to a method for screening a compound useful for treating or preventing a viral infection or a virus-related condition in an individual, comprising at least the steps of: a) determining the ability of a candidate compound to promote the interaction between cbp20 and cbp80 in a sample, and b) selecting the candidate compound that is determined to promote said interaction at step a). The present invention further relates to a method for screening a compound useful for treating or preventing a viral infection or virus-related condition in an individual, comprising at least the steps of: a) determining the ability of a candidate compound to interact with cbp20 or cbp80 in a sample, and b) selecting the candidate compound that is determined to interact with cbp20 or cbp80 at step a).. ... Universite De Montpellier

A new quinoline derivative for use in the treatment and prevention of viral infections

The present invention relates to a quinoline derivative of formula (1) or one of its pharmaceutically acceptable salts. The present invention further relates to said quinoline derivative for medicament and for use in the treatment or prevention of a viral or retroviral infection and in particular aids or an aids-related condition or human immunodeficiency virus (hiv). ... Universite De Montpellier

Quinoline derivatives for use in the treatment or prevention of viral infection

The present invention relates to a quinoline derivative of formula (i) or anyone of its pharmaceutically acceptable salt, or anyone of its metabolites, for use for treating or preventing a viral infection, in particular a hiv infection or a hiv-related condition in a patient; and then terminating said treatment when: the viral load is low or undetectable; and/or the level of cd4+ cell count is maintained or restored. The present invention further relates to a quinoline derivative of formula (i) as defined in claim 1, or anyone of its pharmaceutically acceptable salts and metabolites, for use for treating or preventing a viral infection, in particular a hiv infection or a hiv-related condition in a patient, for which an ineffectiveness or a decline in a prior anti-retroviral treatment effectiveness has been stated and to a quinoline derivative of formula (i) as defined above, or anyone of its pharmaceutically acceptable salts and metabolites, for use for treating or preventing a viral infection, in particular a hiv infection or a hiv-related condition in a patient, wherein the patient is infected by a drug-resistant viral strain, and more particularly by a drug-resistant hiv strain.. ... Universite De Montpellier

Hydrosilane/lewis acid adduct, particularly aluminum, iron, and zinc, method for preparing same, and use of said same in reactions for reducing carbonyl derivatives

Disclosed is an adduct between a lewis acid, preferably aluminum trichloride, iron trichloride, or zinc dichloride, and a hydrosilane;—a method for preparing same; and a method for for reducing, particularly, an aldehyde, a ketone, an α,β-unsaturated ketone, an imine, or an α,β-unsaturated imine.. . ... Universite De Montpellier

Human monoclonal antibodies against orexin receptor type 1

The present disclosure relates to human monoclonal antibodies against orexin receptor type 1 (ox1r, hyprocretin 1) and uses thereof for the treatment of cancer. The antibodies are characterized by their cdrs: nyymn, yisgssrniyyadfvkg, snydgmdv (heavy chain) and agtssdvggsnyvs, pgkap, ssytyystrv (light chain)) or the cdrs having at least 50% or 70% identity with the above listed sequences.. ... Universite De Montpellier

Novel process for preparing synthesis intermediates using products of natural origin and use of the intermediates obtained

Disclosed is a process for preparing a product of formula i: wherein the reaction is catalyzed both by thiamine or a thiamine salt and by ascorbic acid in a form which is free or salified or an organic acid salt of an alkaline metal, preferably sodium acetate, potassium tartrate, sodium succinate, or a reductone, preferably 2-hydroxypropanedial or 2,3-dihydroxycyclopent-2-ene-1-one in an organic solvent.. . ... Universite De Montpellier

Methods and pharmaceutical compositions for treatment of cystic fibrosis

The present invention relates to a method and compositions for the treatment of cystic fibrosis.. . ... Universite De Montpellier

Flavonoid derivative compounds and method for preparing same by depolymerization of condensed tannins

A compound of general formula (i) in which r1, r2, r3 and r5, identical or different, each represent a hydrogen atom or a hydroxyl group, optionally protected by a protecting group. R4 represents a hydrogen atom or an —or7 group, in which r7 represents a hydrogen atom, a protecting group or a gallate group. ... Universite De Montpellier

Methods for screening a subject for a cancer

The present invention relates to methods for screening a subject for a cancer. In particular, the present invention relates to a method (a) for screening a subject for a cancer comprising the steps of i) extracting the cell free nucleic acids from a sample obtained from the subject, ii) determining the total concentration of mitochondrial cell free nucleic acids, ii) determining the total concentration of nuclear cell free nucleic acids iv) calculating the ratio of the level determined at step ii) to the concentration determined at step iii), v) comparing ratio determined at step iv) with a predetermined corresponding reference value and vi) concluding that the subject suffers from a cancer when the ratio determined at step iv) is lower than the predetermined corresponding reference value or concluding that the subject does not suffer from a cancer when the ratio determined at step iv) is higher than the predetermined corresponding reference value.. ... Universite De Montpellier

Pyrroloquinoline derivatives as 5-ht6 antagonists, preparation method and use thereof

This invention concerns pyrroloquinoline derivatives as antagonists of 5-ht6 receptors, to methods for the preparation of these compounds and to novel intermediates useful for their synthesis. The invention also relates to the uses of such compounds and compositions, particularly their use in administering them to patients to achieve a therapeutic effect in schizophrenia, anxiety, depression, maniac depression, epilepsy, obsessive compulsive disorders, mood disorders, migraine, alzheimer's disease, age related cognitive decline, mild cognitive impairment, sleep disorders, eating disorders, anorexia, bulimia, panic attacks, attention deficit hyperactivity disorder, attention deficit disorder, parkinson's disease, huntington's disease, withdrawal from abuse of cocaine, ethanol, nicotine or benzodiazepines, pain, obesity and type-2 diabetes, functional bowel disorder, irritable bowel syndrome. ... Universite De Montpellier

Quinoline derivatives for the treatment of inflammatory diseases

. . The present invention relates to a compound of formula (i) wherein: formula (ii) means an aromatic ring wherein v is c or n and when v is n; q is n or o, provided that r″ does not exist when q is o; r′ independently represent a hydrogen atom or a group chosen among a (c1-c3)alkyl group, a halogen atom, a hydroxy! group, a —coor1 group, a —no2 group, a —nr1r2 group, a morpholinyl or a morpholino group, a n-methylpiperazinyl group, a (c1-c3)fluoroalkyl group, a —o—p(=o)—(or3xor4) group, a (c1-c4)alkoxy group and a —cn group, and can further be a group chosen among: (iia), (iiia) or anyone of its pharmaceutically acceptable salt, for use in the treatment and/or prevention of an inflammatory disease.. . ... Universite De Montpellier

A quinoline derivative for the treatment of inflammatory diseases and aids

The present invention relates to a compound of formula (1) in the form of a base or addition salt with an acid, particularly a pharmaceutically acceptable acid. It further relates to a pharmaceutical composition including the compound and at least one pharmaceutically acceptable excipient, to a process for preparing said compound and to a corresponding intermediate compound.. ... Universite De Montpellier

Methods for predicting the survival time of patients suffering from cancer

The present invention relates to methods for predicting the survival time of patients suffering from cancer. Said methods are based on the quantification and analysis of the cell free nucleic acids that are present in a sample from the patient and typically include the determination of the level of the mutant nucleic acid which contains a mutation of interest, the calculation of the mutation load for said mutation of interest, the calculation of the dna integrity index or a combination thereof.. ... Universite De Montpellier

06/29/17 / #20170183662

Methods and compositions for treating neuropathic pain

The present invention relates to an inhibitor of fxyd2 gene expression for use in a method for treating neuropathic pain in a patient in need thereof. The invention also relates to a pharmaceutical composition comprising an inhibitor of fxyd2 gene expression, wherein said pharmaceutical composition is formulated for a direct administration into the peripheral nervous system (pns) of a patient (e.g., formulated for intrathecal administration).. ... Universite De Montpellier

03/30/17 / #20170088577

Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections

2′ and/or 3′ prodrugs of 1′, 2′, 3′ or 4′-branchednucleosides, and their pharmaceutically acceptable salts and derivatives are described. These prodrugs are useful in the prevention and treatment of flaviviridae infections, including hcv infection, and other related conditions. ... Universite De Montpellier

02/09/17 / #20170037067

New lipophenol compounds and uses thereof

The present invention relates to a compound of formula (i) wherein: —i is 0 or 1; j is 0 or 1; k is 0 or 1; —r1 and r2 are in particular h, (c1-c12)alkyl, or a group of formula c(o)r; —r is a, linear or branched, alkyl radical, comprising at least 19 carbon atoms; —r3 is h and k=0 when j=1; or, when j=0, r3 is —c(o)r or -l-c(o)r; —l, u and l″ are linkers; wherein, when j=0, at least one of the groups r1; r2 and r3 comprises a radical r.. . ... Universite De Montpellier








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Universite De Montpellier in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Universite De Montpellier with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###